Back to People & Entities
Karus Therapeutics, Afferent
Organization
1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
Document Mentions (1)
New Leaf Ventures III LP - PPM (Control 257 - Boris Nicolik).pdf
1 mentionHOUSE_OVERSIGHT_024003_sub_001 - HOUSE_OVERSIGHT_024102
Source: House Oversight Committee
mber 2008 and concentrates on biopharmaceutical investing. He is currently on the boards of directors of Array BioPharma (NASDAQ: ARRY), Neuronetics, Karus Therapeutics, Afferent, Calchan and Convergence, the latter three investments resulting from spin-outs from Roche (Afferent) and GSK (Calchan & Convergence), respectively.
Sponsored
Connected Entities
No connected entities